维普期刊资源整合服务平台（V6.5）

208篇 您的检索式：作者名="Maemondo"

选中清除导出查看参考文献查看引证文献引用追踪共11页首页上一页第1页下一页末页 /11 跳转

	题名	作者	年代	出处	被引量
1	First-line gefitinib versus first-line chemotherapy by carboplatin(CBDCA) plus paclitaxel (TXL) in non-small cell lung cancer(NSCLC) patients (pts) with EGFR mutations : A phase III study (002) by North East Japan Gefitinib Study Group 显示文摘	Kobayashi K Inoue A Maemondo M	2009	J Clin Oncol2009，27，15：	1
2	First-line gefitinib versus first-line chemotherapy by carboplatin (CBDCA)plus paelitaxel (TXL) in non-small cell lung cancer(NSCLC) patients with EGFR mutations: a phase Ill study (002) by North East Japan (NEJ) Gefitinib Study Group显示文摘	Kobayashi K lnoue A Maemondo M	2009	Journal of Clinical Oncology2009，27，：	1
3	Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR显示文摘	Maemondo M Inoue A Kobayashi K		0，，：	1
4	Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR显示文摘	Maemondo M Inoue A Kobayashi K	2010	N Engl J Med2010，362，25：	1
5	Severe acute interstitial pneumonia and gefitinib 显示文摘	Inoue A Saijo Y Maemondo M Gomi K Tokue Y Kimura Y	2003	Lancet2003，361，9352：	1
6	A phase IIstudy of palonosetron combined with dexamethasone toprevent nausea and vomiting induced by highly emetogenicchemotherapy 显示文摘	Maemondo M Masuda% Sekine I	2013	Ann Oncol2013，20，11：	1
7	Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR 显示文摘	Maemondo M Inoue A Kobayashi K	2010	N Engl J Med2010，362，25：	1
8	Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR显示文摘	Maemondo M Inoue A Kobayashi K		0，，25：	1
9	First-line gefitinib versus first-line chemotherapy by carboplatin (CBDCA) plus paclitaxel (TXL) in non-small cell lung cancer (NSCLC) patients with EGFR mutations: a phase III study (002) by North east Japan Gefitinib Study Group 显示文摘	Kobayashi K Inoue A Maemondo M	2009	J Clin Oncol2009，27，15：	1
10	Gene therapy with secretory leukoprotease inhibitor promoter-controlled replication-competent adenovirus for non-small cell lung cancer显示文摘	Maemondo M Saijo Y Narumi K	2004	Cancer Res2004，64，13：	1
11	Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR显示文摘	MAEMONDO M INOUE A KOBAYASHI K	2010	N EnglJ Med2010，362，25：	1
12	Gefitinib or chemotherapy for non-small cell lung cancer with mutated EGFR显示文摘	Maemondo M Inoue A Kobayashi K		0，，25：	1
13	Gefitinib or Chemotherapyfor Non-Small-Cell Lung Cancer with Mutated EGFR 显示文摘	Maemondo M Inore A Kobayashi K	2010	N Engl JMed2010，362，25：	1
14	Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR显示文摘	Maemondo M Inoue A Kobayashi K	2010	N Engl Med2010，362，25：	1
15	Geiftinib or chemotherapy for non-small-cell lung cancer with mutated EGFR显示文摘	Maemondo M Inoue A Kobayashi K	2010	N Engl J Med2010，362，25：	1
16	Gefitinib or chemotherapy for non-small cell lung cancer with mutated EGFR显示文摘	Maemondo M Inoue A Kobayashi K		0，，25：	1
17	Gefitinib or chemotherapy for non -small-cell lung cancer with mutated EGFR显示文摘	Maemondo M Inoue A Kobayashi K	2010	N Engl J Med2010，362，25：	1
18	Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR显示文摘	Maemondo M Inoue A Kobayashi K	2010	N Engl J Med2010，362，25：	1
19	C, efitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR 显示文摘	Maemondo M Inoue A Kobayashi K et O2	2010	N Engl J Med2010，362，：	1
20	Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR显示文摘	Maemondo M Inoue A Kobayashi K	2010	N Engl J Med2010，362，25：	1

返回顶部每页显示：

共11页首页上一页第1页下一页末页 /11 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示